1-1046551-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000379370.7(AGRN):āc.3066A>Gā(p.Ser1022=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.892 in 1,610,386 control chromosomes in the GnomAD database, including 647,914 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.80 ( 51075 hom., cov: 30)
Exomes š: 0.90 ( 596839 hom. )
Consequence
AGRN
ENST00000379370.7 synonymous
ENST00000379370.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.03
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 1-1046551-A-G is Benign according to our data. Variant chr1-1046551-A-G is described in ClinVar as [Benign]. Clinvar id is 128297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-1046551-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.94 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGRN | NM_198576.4 | c.3066A>G | p.Ser1022= | synonymous_variant | 18/36 | ENST00000379370.7 | NP_940978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGRN | ENST00000379370.7 | c.3066A>G | p.Ser1022= | synonymous_variant | 18/36 | 1 | NM_198576.4 | ENSP00000368678 | P1 | |
AGRN | ENST00000651234.1 | c.2751A>G | p.Ser917= | synonymous_variant | 17/38 | ENSP00000499046 | ||||
AGRN | ENST00000652369.1 | c.2751A>G | p.Ser917= | synonymous_variant | 17/35 | ENSP00000498543 | ||||
AGRN | ENST00000620552.4 | c.2652A>G | p.Ser884= | synonymous_variant | 18/39 | 5 | ENSP00000484607 |
Frequencies
GnomAD3 genomes AF: 0.802 AC: 121546AN: 151638Hom.: 51078 Cov.: 30
GnomAD3 genomes
AF:
AC:
121546
AN:
151638
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.887 AC: 216630AN: 244354Hom.: 97400 AF XY: 0.891 AC XY: 118804AN XY: 133338
GnomAD3 exomes
AF:
AC:
216630
AN:
244354
Hom.:
AF XY:
AC XY:
118804
AN XY:
133338
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.902 AC: 1315696AN: 1458630Hom.: 596839 Cov.: 79 AF XY: 0.902 AC XY: 654709AN XY: 725646
GnomAD4 exome
AF:
AC:
1315696
AN:
1458630
Hom.:
Cov.:
79
AF XY:
AC XY:
654709
AN XY:
725646
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.801 AC: 121566AN: 151756Hom.: 51075 Cov.: 30 AF XY: 0.805 AC XY: 59735AN XY: 74236
GnomAD4 genome
AF:
AC:
121566
AN:
151756
Hom.:
Cov.:
30
AF XY:
AC XY:
59735
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3142
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 19, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2013 | - - |
Congenital myasthenic syndrome 8 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at